Evaluation of the Impact of In-Person and Telemedicine-Based Medical Education on Diabetes Care and Outcomes in Hospitalized Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Improvement in medical knowledge regarding inpatient hyperglycemia
研究概览
简要总结
This clinical trial aims to evaluate whether a structured medical education strategy can improve the quality of care provided to hospitalized patients with diabetes or hyperglycemia. Internal medicine residents from four university hospitals in southern Brazil are assigned to two groups: an intervention group receiving a 30-minute online lecture and 30 days of educational follow-up via WhatsApp®, and a control group receiving no additional training.
The primary goal is to assess changes in physicians' knowledge about inpatient glycemic control. Secondary goals include evaluating the quality of insulin prescriptions, rates of hyperglycemia and hypoglycemia, and hospital length of stay.
详细描述
Hospital hyperglycemia is associated with increased morbidity, length of stay, and hospital costs, especially when not properly managed. Many internal medicine teams lack adequate training on glycemic control in hospitalized patients, and guidelines are not consistently followed in clinical practice.
This multicenter, randomized, open-label trial is designed to evaluate whether a telemedicine-based educational intervention can improve medical knowledge and clinical management of inpatient hyperglycemia. Internal medicine residents from four university hospitals in southern Brazil are randomized by clinical team into two groups: one receives a 30-minute online class and continued support via WhatsApp® for 30 days; the control group receives no intervention.
Medical knowledge is assessed using a validated questionnaire before and after the intervention. Secondary outcomes include the appropriateness of glycemic monitoring and insulin prescriptions, frequency of hyper- and hypoglycemia and hospital length of stay.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Internal medicine residents from clinical teams at the participating university hospitals in southern Brazil.
- •Residents assigned to clinical teams during the intervention month.
- •Provided informed consent to participate in the study.
排除标准
- •Residents on vacation during the intervention month.
- •Residents from teams supervised by endocrinologists.
- •Refusal to participate in the study.
研究组 & 干预措施
Telemedicine Education Group
Internal medicine residents in this group will receive a 30-minute online theoretical class on hospital hyperglycemia, taught by hospital-based endocrinologists. After the class, for 30 days, participants will be included in a continuing medical education group via the WhatsApp® application, where they will receive short educational videos and supporting materials related to diabetes and inpatient glycemic control.
干预措施: Educational Intervention via Telemedicine (Behavioral)
Routine Clinical Practice Group
Internal medicine residents in this group will not receive any theoretical class or continuing education intervention. They will continue their standard clinical duties and usual care practices during the study period, without additional materials or support related to inpatient diabetes management.
结局指标
主要结局
Improvement in medical knowledge regarding inpatient hyperglycemia
时间窗: Baseline and 30 days post-intervention
Medical knowledge will be assessed using a structured and validated questionnaire on hospital hyperglycemia and diabetes, administered before and 30 days after the intervention. The questionnaire includes multiple-choice clinical case scenarios related to glycemic monitoring, insulin use, treatment errors, and glycemic targets.
次要结局
- Occurrence of hyperglycemia(Last 5 days of hospitalization during the 30-day intervention period)
- Quality of insulin prescription(Last 5 days of hospitalization during the 30-day intervention period)
- Time in glycemic target range(Last 5 days of hospitalization during the 30-day intervention period)
- Occurrence of hypoglycemia(Last 5 days of hospitalization during the 30-day intervention period)
- Glycated hemoglobin ordered at hospital admission(During the 30-day intervention period)
- Length of hospital stay(During the 30-day intervention period)
研究者
Jivago da Fonseca Lopes
Principal Investigator, Endocrinologist, Catholic University of Pelotas
Catholic University of Pelotas